Drimva

Legend Biotech

Director, Head of Commercial Learning & Development

$194K–$254K

United States · Director · Full-time · Posted Oct 14, 2026

Experience
12+ years of progressive commercial experience in sales, clinical education, sales training, and/or marketing; 10+ years in Commercial Training; 7+ years of Oncology experience; 7+ years of training, capability-building, or commercial leadership experience; 5+ years leading and managing a team.
Education
Bachelor’s degree required; advanced degree preferred.
Visa sponsorship
Applicants must be authorized to work in the United States; employment eligibility is verified through E-Verify.

About the job

Leads Legend Biotech’s commercial learning strategy and team, developing and delivering training programs that build capability and improve performance across commercial roles.

What you'll do

  • Set commercial training priorities, identify capability gaps, and lead the training team and agency partners.
  • Oversee cross-functional learning programs, promotional training content, and training at major commercial events.
  • Measure learning impact, manage resources and governance, and ensure training complies with customer-interaction SOPs.

What they ask for

  • Bachelor’s degree required.
  • 12+ years of progressive commercial experience in sales, clinical education, sales training, and/or marketing.
  • 10+ years in Commercial Training; 7+ years of Oncology experience; 7+ years of training, capability-building, or commercial leadership experience; and 5+ years leading and managing a team.
  • Demonstrated experience leading a commercial training function and developing and executing commercial capability strategies across field teams.

Nice to have

  • Advanced degree in Business, Life Sciences, Organizational Leadership, Education, or a related field.
  • Experience supporting the launch or growth of an Oncology product.

Pay

$193,629 — $254,137 USD (base salary)

Tools

MS Office, Excel, PowerPoint, Word

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 6, 2026 (UTC)